NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Aligning Medications With What Matters Most

CompletedNA

Sponsor: Johns Hopkins University

Conditions: Polypharmacy, Alzheimer Disease and Related Dementias

Interventions: Pharmacist-led deprescribing intervention

Countries: United States

The Aligning Medications with What Matters Most (ALIGN) study will assess the feasibility and preliminary efficacy of a deprescribing intervention to reduce medication regimen complexity and treatment burden for people living with dementia (PLWD) and their care partners.

Eligibility overview

Sex: ALL

Age: 65 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age 65 or greater
* Diagnosis of dementia from International Classification of Diseases (ICD) -9 or ICD-10 codes
* At least one other chronic condition
* Five or more chronic medications (to include all prescription and over-the-counter medications, both scheduled and as needed)
* Have a primary care physician at the pilot clinic who has enrolled in the study; this will be defined as having had at least 1 previous visit with that physician

Care partners:

\- Family or other companions age 21 years or greater who regularly help the patient with managing medications

Exclusion Criteria:

* As both the pilot and the planned pragmatic trial will be based in primary care, individuals residing in long term care facilities or enrolled in hospice will be excluded.
* Individuals who cannot converse comfortably in English will be excluded because the FCMAHS has not been validated in other languages.

Locations (2)

Aurora, Colorado, United States
Baltimore, Maryland, United States